|
血栓性微血管病的研究进展 |
| |
sp;B. Thrombotic thrombocytopenic purpura in children pathophysiologic mechanisms and their clinical significance［J］. Med Wieku Rozwoj， 2005， 9(4):753761.
[6]TSAI HM.Current concepts in thrombotic thrombocytopenic purpura［J］. Annu Rev Med， 2006，57:419436.
[7]TARR PI, GORDON CA, CHANDLER WL. Shigatoxinproduciing escherichia coli and haemolytic uraemic syndrome［J］.Lancet，2005， 365:10731086.
[8]FORTIN MC, RAYMOND MA, MADORE F, et al. Increased risk of thrombotic microangiopathy in patients receiving a cyclosporinsirolimus combination［J］. Am J Transplant，2004，4:946952.
[9]ROCK G, ANDERSON D, CLARK W. et al. Dose cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet［J］. Br J Haematol， 2005，129:7986.
[10] SADLER JE,MOAKE JL,MIYATA T, et al. Recent advances in thrombotic thrombocytopenic purpura ［J］. Hematology，2004，124（3）：407423.
[11] YOMTOVIAN R, NIKLINSKI W,SILVER B,et al. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature［J］.Br J Hematol， 2004，124(6):787795.
[12] KREMER HOVINGA JA,STUDT JD,DEMARMELS BISSITUTTI F,et al.Splenectomy in relapsing and plasmarefractory acquired thrombotic thrombocytopenic purpura［J］.Haematologica，上一页 [1] [2] [3] [4] [5] 下一页
上一个医学论文： 凝血酶原复合物的临床应用
下一个医学论文： 肝素联合华法林治疗脑静脉窦血栓形成12例临床探讨
|
|
|
|
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文